Evaluation of Synergetic Anticancer Activity of Berberine and Curcumin on Different Models of A549, Hep-G2, MCF-7, Jurkat, and K562 Cell Lines. [electronic resource]
Producer: 20160413Description: 354614 p. digitalISSN:- 2314-6141
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Berberine -- administration & dosage
- Cell Survival -- drug effects
- Curcumin -- administration & dosage
- Dose-Response Relationship, Drug
- Drug Synergism
- Hep G2 Cells
- Humans
- Jurkat Cells
- K562 Cells
- MCF-7 Cells
- Neoplasms, Experimental -- drug therapy
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.